|
ADMP
|
Adamis Pharmaceuticals Corporation
|
US
|
NASDAQ
|
|
APLS
|
Apellis Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
AZN
|
Astrazeneca PLC
|
US
|
NASDAQ
|
|
BLPH
|
Bellerophon Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DVAX
|
Dynavax Technologies Corporation
|
US
|
NASDAQ
|
|
GTLS
|
Chart Industries, Inc.
|
US
|
NYSE
|
|
HZNP
|
Horizon Pharma, Inc.
|
US
|
NASDAQ
|
|
INGN
|
Inogen, Inc
|
US
|
NASDAQ
|
|
INVA
|
Innoviva, Inc.
|
US
|
NASDAQ
|
|
IXHL
|
Incannex Healthcare Limited
|
US
|
NASDAQ
|
|
LUNG
|
Pulmonx Corporation
|
US
|
NASDAQ
|
|
OPK
|
OPKO Health Inc.
|
US
|
NASDAQ
|
|
PULM
|
Pulmatrix, Inc.
|
US
|
NASDAQ
|
|
VRNA
|
Verona Pharma plc
|
US
|
NASDAQ
|
|
VTVT
|
vTv Therapeutics Inc.
|
US
|
NASDAQ
|
|
ADR
|
Adherium Ltd
|
AU
|
ASX
|
|
PXS
|
Pharmaxis Ltd.
|
AU
|
ASX
|
|
RMD
|
ResMed Inc. (CHESS)
|
AU
|
ASX
|
|
ALPMF
|
Astellas Pharma Inc
|
US
|
OTC
|
|
ALPMY
|
Astellas Pharma Inc
|
US
|
OTC
|